已收盘 11-08 16:00:00 美东时间
0.000
0.00%
** Shares of drug developer Altimmune ALT.O fall 6.7% to $4.91 premarket ** Co says Chairman Jerry Durso will take over as chief executive officer on January 1, 2026, succeeding Vipin Garg, who has le...
2025-12-01 20:47
Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is voluntarily withdrawing its liver disease treatment from the U.S. market following a request from the Food and Drug Administration....
2025-09-11 20:38
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, in...
2025-08-21 19:03
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
2023-10-26 20:49
NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities...
2023-10-24 08:55
越来越多的明星biotech,选择“退出”创新药市场。 Mirati是最新的卖身者。然而,与大部分biotech由于弹尽粮绝、身处险境而寻求卖身不同,Mira...
2023-10-10 08:04
NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims con...
2023-10-05 01:52
Upgrades For Telos Corp (NASDAQ:TLS), Northland Capital Markets upgraded the pr...
2023-09-27 23:00
Immunovant正在开发抗体药物IMVT-1402,小摩表示,若该药物在后续研究中取得成功,或将为同类药物中最好的;Intercept制药隔夜上涨超79%,同意以每股19美元的价格被收购>>
2023-09-27 15:11